This is the authors' abstract. We don't add key points for this paper.
Wearable electrodermal activity (EDA) monitoring enables assessment of stress-related physiological changes in daily life, but new devices require validation. This study evaluated the newly introduced EmbracePlus against the Shimmer3 GSR+, used as a research-grade wrist-based comparator. Healthy volunteers (n = 53; n = 41 valid paired recordings) completed breathing exercises, a Stroop task, and a virtual reality (VR) height stressor while wearing both devices simultaneously on the non-dominant wrist. Agreement was assessed at signal, parameter, and event levels for mean phasic activity, skin conductance level (SCL), summed skin conductance response (SCR) amplitude/min, and SCR count/min. Mean signal-level cross-correlation was r = 0.30. At the parameter level, only 44% of SCL, 24% of SCR amplitude/min, and 5% of SCR count/min differences fell within a priori acceptable boundaries, and regression analyses indicated proportional bias for mean phasic activity, summed SCR amplitude/min and SCR count/min. At the event level, Shimmer3 detected increases across all four EDA metrics during both stress tasks (all p < 0.001). EmbracePlus showed increases across all four metrics during VR (all p < 0.001), whereas during Stroop only mean phasic activity (p = 0.001) and SCL (p < 0.001) increased. EmbracePlus and Shimmer3 are therefore not interchangeable for absolute EDA assessment, and EmbracePlus validity depends on stressor intensity and metric selection.
No takes yet. Share an insight, caveat, or question.
Peeters et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: